NCT01779115

Brief Summary

A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.

Trial Health

73
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126,000

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1998

Completed
15.1 years until next milestone

First Submitted

Initial submission to the registry

January 28, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 30, 2013

Completed
87.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2100

Expected
Last Updated

January 31, 2013

Status Verified

January 1, 2013

Enrollment Period

103 years

First QC Date

January 28, 2013

Last Update Submit

January 30, 2013

Conditions

Keywords

Registry,Diabetes,Health Maintenance Organization

Outcome Measures

Primary Outcomes (1)

  • Prevalence rates of Diabetes

    Up to 100 years

Secondary Outcomes (3)

  • Rates of performance of eye examinations,blood and urine tests

    up to 100 years

  • Number and types of Drugs purchased

    100 years

  • Number of visits to physician offices

    up to 100 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Diabetes patients.

You may qualify if:

  • Diabetic patient was defined according to the criteria suggested by American Diabetes Association - symptoms diagnosed as diabetes and fasting plasma glucose \>125 mg/dl (7.0 lmol/l) or casual (namely, any time of day without regard to time since last meal) plasma glucose concentration P200 mg/dl. In order to reach maximal validity, we also included any patient who answered to one of the following: (1) purchased at least two hypoglycemic medications or single insulin dose during 6 months. (2) Had HbA1c result of at least 7.25%. HbA1c of 6.5% was used as entry criterion to registry only when the patient was diagnosed as diabetic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maccabi Healthcare Services

Tel Aviv, 68125, Israel

Location

Related Publications (2)

  • Chodick G, Heymann AD, Shalev V, Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol. 2003;18(12):1143-6. doi: 10.1023/b:ejep.0000006635.36802.c8.

  • Heymann AD, Chodick G, Halkin H, Karasik A, Shalev V, Shemer J, Kokia E. The implementation of managed care for diabetes using medical informatics in a large Preferred Provider Organization. Diabetes Res Clin Pract. 2006 Mar;71(3):290-8. doi: 10.1016/j.diabres.2005.07.002. Epub 2005 Aug 19.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Gabriel Chodick, PHD

    Head,Epidemiology & Database Reseaech Unit, Medical Division, Maccabi H.S

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2013

First Posted

January 30, 2013

Study Start

January 1, 1998

Primary Completion (Estimated)

December 1, 2100

Last Updated

January 31, 2013

Record last verified: 2013-01

Locations